ArticleBreast cancer research : BCR2026

High levels of circulating miR-19a-3p in patients with metastatic HER2 + breast cancer are associated with a favorable prognosis and anti-tumor immune responses.

Evan N Cohen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.